A Phase 1b, Randomized, Double-Blind, Placebo Controlled, Single-Dose Ranging Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GS-5806 in Subjects < 24 Months of Age [...] (2013–2014)

Grant type:
Gilead Clinical Trial
Researchers:
  • NHMRC Sr Principal Research Fellow
    Child Health Research Centre
    Faculty of Medicine
Funded by:
Gilead Sciences Pty Limited